The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -1,740,564 | -2,761,084 |
| Depreciation and amortization | 555,156 | 1,130,600 |
| Amortization of right of use assets - financing | 5,050 | 12,237 |
| Amortization of right of use assets - operating lease | 63,272 | 121,529 |
| Stock based compensation | 246,814 | 596,073 |
| Derecognition of contingency and grant | 0 | 0 |
| Amortization of financing fees | 0 | 0 |
| Impairment and amortization of referral and support services agreement advance | 0 | 0 |
| Adjustment to expected losses on accounts receivable | 21,771 | -17,316 |
| Deferred income tax expense | 5,352 | 2,676 |
| Accounts receivable | 214,116 | -2,825,264 |
| Accounts payable | - | 382,182 |
| Prepaid expenses and other current assets and other assets | 35,344 | 31,047 |
| Accrued expenses and other liabilities | 722,076 | -2,358,189 |
| Accounts payable | -765,360 | - |
| Lease liability - operating lease | -65,976 | -126,182 |
| Net cash used in operating activities | -1,584,051 | -223,257 |
| Purchases of equipment and capitalized development costs | 382,551 | 858,441 |
| Net cash provided by/(used in) investing activities | -382,551 | -858,441 |
| Net proceeds financed receivables | 3,383,293 | - |
| Principal payments on finance lease obligations | 5,051 | 12,237 |
| Proceeds from at-the-market sales | 1,149,288 | 1,128,838 |
| Net taxes paid on restricted stock unit grants exercised | 187,697 | 358,960 |
| Net cash provided by/(used in) financing activities | 3,210,995 | 757,641 |
| Net change - cash | 1,244,393 | -324,057 |
| Cash and cash equivalents at beginning of period | 2,459,245 | - |
| Cash and cash equivalents at end of period | 3,379,581 | - |
Inuvo, Inc. (INUV)
Inuvo, Inc. (INUV)